Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001214659-25-007880·REVIVA PHARMACEUTICALS HOLDINGS, INC.
Schedule 13G ownership disclosure
REVIVA PHARMACEUTCLS HLDGS I
Common Stock, par value $0.0001 per share · CUSIP: 76152G100
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TANG CAPITAL MANAGEMENT, LLC
Shares: 3,910,304.00 · Class: 7.80%
- KEVIN TANG
Shares: 3,910,304.00 · Class: 7.80%
- TANG CAPITAL PARTNERS, LP
Shares: 3,656,983.00 · Class: 7.29%
- TANG CAPITAL PARTNERS INTERNATIONAL, LP
Shares: 223,321.00 · Class: 0.45%
- TANG CAPITAL PARTNERS III, INC
Shares: 24,000.00 · Class: 0.05%
- TANG CAPITAL PARTNERS IV, INC
Shares: 6,000.00 · Class: 0.01%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-007880
- Form type
- SCHEDULE 13G/A
- Filer
- REVIVA PHARMACEUTICALS HOLDINGS, INC.
- CIK
- CIK 1742927
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership